A
Abdominal pain, signs and symptoms associated with surgical intervention in childrens with, P21
Acute intravenous (IV) alcohol, subjective and motor responses to, clamp vs. oral-mimic infusion paradigms, MP4
Acute ischemic stroke patients, plasma protein changes after tPA treatment in, P17
Acute kidney injury (AKI), association between urinary biomarkers and mortality, 20
Acute multifocal placoid pigment epitheliopathy (AMPPE), recurrent ischemic stroke in patient with, P13
Acute myocardial infarction (AMI)
nationwide inpatient sample analysis of in-hospital mortality after CO poisoning, 14
PCI for, in patients with RA, 5
Adipocyte exosomal miRNAs, effects of, from obese patients in lung disease, 15
Adolescents
food allergy, risk factors for non-adherence in, P1
LAR in kidney transplant recipients, 10
Adults
expression of cardiolipin biosynthesis and remodeling enzymes in heart failure, 25
NEC in, with acute leukemia, P10
opthalmologic findings associated with recurrent stroke in, P13
signal processing of polysomnography to identify airflow-independent features of OSA in, 24
Advanced glycation end products (AGEs), effects on pro-atherogenic changes in cholesterol transport, 26
Aging, progenitor cell mitotic dyssynchrony due to, 27
Airway epithelial progenitor cells, mitotic dyssynchrony induced TGF-?1 in, 2
Airway inflammation, upper and lower, modulates the phenotypical expression of OSA in children, MP10
Alcoholic Hepatitis (AH), temporal trend of hospitalizations cost and mortality in United States, P6
Alpha II spectrin breakdown product (AIISBDP), biomarker for neurological injury in infants with CHD undergoing CPB and DHCA, 8
Artificial neural networks model, impact of noninvasive markers on mortality prediction and CV model performance, 13
Asthmatic epithelium, impact of estrogen and TGF-?1 on fibronectin mRNA and protein expression in, 12
Atopic patients, IL-33 assesment and its effect on cholesterol transport in, 9
Automated adverse-event (AE) detection, factors associated with doubling in creatinine from baseline in children through, P25
B
B-cell lymphoma, lateral medullary syndrome and, P14
Bone healing, BMP-2 for, effect of FGF-2 on calvarial bone defects, 21
Bone mineral density (BMD), influence of, on fracture risk in overweight children, 23
Bone morphogenetic protein 2 (BMP-2), effect of FGF-2 on calvarial defects in mice, 21
Bronchodilators, response in patients with CF, MP11
C
Calvarial bone defect, BMP-2 synergizes bone healing effect of FGF-2 on, 21
Capsaicin, effects on carotid-radial artery pulse wave velocity measurements, MP2
Carbon monoxide poisoning, AMI and in-hospital mortality after, 14
Cardiolipin (CL), biosynthesis and expression in adult heart failure, 25
Cardiopulmonary bypass (CPB), AIISBDP biomarker for neurological injury in infants with CHD undergoing, 8
Cardiovascular (CV) risk
carotid artery GSM relationship to anatomic and functional measures of, MP1
effects of AGEs on pro-atherogenic changes in cholesterol transport for, 26
Carotid artery
GSM relationship to anatomic and functional measures of CV risk, MP1
markers, impact on mortality prediction and CV model performance, 13
Carotid-radial pulse wave velocity, effects of topical capsaicin on, MP2
Chest, ‘tree-in-bud’ appearance on CT scan of, P24
Childrens
with abdominal pain, signs and symptoms associated with surgical intervention, P21
factors associated with creatinine doubling through automated adverse-event (AE) detection, P25
Cholesterol efflux genes, effects of atherogenic properties of rheumatoid arthritis plasma on, MP12
Cholesterol transport, IL-33 assesment and its effect on, in atopic patients, 9
Chronic inflammatory demyelinating polyneuropathy (CIDP), relapse of, after influenza vaccine, P12
Chronic lymphocytic leukemia (CLL), a report on neurological involvement in, P9
Clamp vs. oral-mimic infusion paradigms, subjective and motor responses to acute IV alcohol, MP4
Congenital heart disease, AIISBDP biomarker for neurological injury in infants with, CPB and DHCA for, 8
Cool therapy, glyco-proteomic study of, in global ischemic brain injury post cardiac arrest, P16
Creatinine doubling, factors associated with, in children through automated adverse-event (AE) detection, P25
CT scan, ‘tree-in-bud’ appearance of chest, P24
Cystic fibrosis (CF)
response to bronchodilators in patients with, MP11
secretome, proteomic profiling of, 4
D
Deep hypothermic cardiac arrest (DHCA), AIISBDP biomarker for neurological injury in infants with CHD undergoing CPB and, 8
Deep venous thrombosis, May-Thurner syndrome in postpartum period as cause for, P11
Delirium, refractory, basics of, P15
Diabetes, effects of AGEs on pro-atherogenic changes in cholesterol transport, 26
Dual stent migration, complications of, P26
Dyssynchrony, directionality of mitotic, in airway epithelial progenitor cells, 2
E
Ejection fraction (EF), risk factors for all-cause readmission after HF admission in patients with, 1
Elastic cartilage engineering, PLA nanofiber-filled slurry from UCMSCs for improved, 18
Elders, factors affecting stroke outcome and hospital resource utilization among, P8
Emergency department
parent perspective on return visits, P22
pediatrics
current practices and experiences of PEM fellows with debriefing after medical resuscitations, MP9
implementation of a structured handoff tool SOUND in, P19
sumatriptan for migraine headaches in, MP8
End-of-life care, effect of palliative care consultations in, of newborns, P20
Endoscopic gastrostomy, predictors of mortality after percutaneous, P5
Eosinophilic esophagitis (EoE), quality of life in racially diverse cohort of children with, P2
Epithelial ovarian (EOV) carcinoma, genetic counseling and testing among patients with, P18
Epithelial tubal carcinoma (ETC), genetic counseling and testing among patients with, P18
Estrogen, impact on fibronectin mRNA and protein expression in asthmatic epithelium, 12
Euglycemic diabetic ketoacidosis, complicated, in pregnancy, P4
Extracorporeal life support, idiopathic pulmonary hemosiderosis in a five week old infant with, P3
F
Febrile neonates, practice patterns in management of, with no lumbar puncture, 22
FGF-2 signaling, in human podocytes, HIV-Tat essential for targeting Tat to lipid rafts (LR) and its regulation of, 28
Food allergy
lymphocytic colitis mimiking, P7
risk factors for non-adherence in adolescents with, P1
Forearm fractures, BMD in overweight children with and without, 23
G
Genetic counseling, among a series of consecutive patients with ovarian, tubal, or peritoneal carcinoma, P18
Global ischemic brain injury post cardiac arrest, glyco-proteomic study of cool therapy in, P16
Glyco-proteomic study, in global ischemic brain injury post cardiac arrest, P16
Grey scale median (GSM), carotid artery, relationship to anatomic and functional measures of CV risk, MP1
H
Health-related quality of life (HRQL), in a racially diverse cohort of children with EoE, P2
Heart failure (HF)
expression of cardiolipin biosynthesis and remodeling enzymes in adults, 25
risk factors for all-cause readmission after, in patients with preserved or reduced ejection fraction, 1
HIV positive ED patients, sero-prevalence impacts patient care and outcome for, MP7
HIV-Tat, essential for targeting Tat to lipid rafts (LR) and its regulation of FGF-2 signaling in human podocytes, 28
Human bronchial epithelial (HBE) cells, identifying directional secretome of in vitro normal primary, 6
Human lung epithelial cells, repression of MUC5AC gene expression by classical and dissociative steroids, 19
Human podocytes, HIV-Tat essential for targeting Tat to lipid rafts (LR) and its regulation of FGF-2 signaling in, 28
Human umbilical cord mesenchymal stem cells (UCMSCs), PLA nanofiber-filled slurry for improved elastic cartilage engineering from, 18
Hyperemia, determinants of post-ischemic reactive, StO2, 3
I
Idiopathic pulmonary hemosiderosis (IPH), extracorporeal life support for a five week old infant with, P3
IL-33, assesment and its effect on cholesterol transport in atopic patients, 9
Iliac vein compression syndrome, extensive deep venous thrombosis caused by, in postpartum period, P11
Infants, IPH in, extracorporeal life support in a five week old, P3
Influenza vaccine, relapse of CIDP after, P12
In-hospital mortality, in patients with TTP, 11
Intensive care, guidelines for RBC transfusion in, MP5
K
Kidney transplant, late acute rejection in pediatric and adolescent recipients, 10
L
Late acute rejection (LAR), in pediatric and adolescent kidney transplant recipients, 10
Lateral medullary syndrome, B-cell lymphoma mimicking, P14
Lead testing, for pediatric use, of red blood cell products, P23
Leukemia, NEC in adults with acute, P10
Lumbar puncture, practice patterns in management of febrile neonates with no, 22
Lung disease, effects of adipocyte exosomal miRNAs from obese patients in, 15
Lymphocytic colitis, food allergy and, P7
M
Mandible fractures, presence of third molars predicts increased, MP3
May-Thurner syndrome, extensive deep venous thrombosis caused by, in postpartum period, P11
MicroRNAs, favorable outcomes in ovarian cancer with circulating, from miR17-92 family, 7
Migraine headaches, sumatriptan for, in pediatric emergency department, MP8
MiR17-92 family, favorable outcomes in ovarian cancer with circulating MicroRNAs from, 7
Mitotic dyssynchrony, directionality of, in airway epithelial progenitor cells, 2
MUC5AC gene expression, repression of, in human lung epithelial cells by classical and dissociative steroids, 19
Mucosal disorders, lymphocytic colitis mimickngi food allergy and, P7
N
Neutropenic enterocolitis (NEC), in adults with acute leukemia, P10
Newborns, effect of palliative care consultations in end-of-life care of, P20
Non-adherent behavior, risk factors for, in adolescents with food allergy, P1
O
Obesity, effects of adipocyte exosomal miRNAs mediate on lung disease, 15
Obstructive sleep apnea (OSA)
signal processing of polysomnography to identify airflow-independent features of, in adults, 24
upper and lower airway inflammation modulate the phenotypical expression of, in children, MP10
Ovarian cancer (OvCa), circulating microRNAs from miR17-92 family for, 7
Overweight children, influence of BMD on with and without forearm fractures in, 23
P
Palliative care consultations, effect in end-of-life care of newborns, P20
Patent foramen ovale (PFO), proteomic profiles in long term follow-up of, in stroke patients, 29
Patient demographic characteristics, comparison of peak troponin (cTnI) levels based on, 16
Pediatric emergency medicine fellows, current practices and experiences with debriefing after medical resuscitations, MP9
Pediatrics
current practices and experiences of PEM fellows with debriefing after medical resuscitations, MP9
extracorporeal life support for a five week old infant with idiopathic pulmonary hemosiderosis, P3
febrile neonates, practice patterns in management of, with no lumbar puncture, 22
HRQL for a racially diverse cohort with EoE, P2
LAR in kidney transplant recipients, 10
lead testing of red blood cell products, P23
sumatriptan for migraine headaches in emergency department, MP8
upper and lower airway inflammation modulates the phenotypical expression of OSA, MP10
Percutaneous coronary intervention (PCI)
characteristics and outcomes of, for AMI in patients with RA, 5
outcomes among elder patients with STEMI, 17
Percutaneous endoscopic gastrostomy (PEG), predictors of mortality after, P5
Peritoneal carcinoma (PC), genetic counseling and testing among patients with, P18
Poly-lactic acid (PLA) nanofiber, from UCMSCs, for improved elastic cartilage engineering, 18
Polysomnography, signal processing of, in identifying airflow-independent respiratory features of OSA in adults, 24
Post-ischemic reactive hyperemia, tissue oxygen saturation (StO2), determinants of, 3
Pregnancy, complicated euglycemic diabetic ketoacidosis in, P4
Progenitor cell mitotic dyssynchrony, effects of aging on, 27
Proteomic profiling, CF secretome, 4
Pulse wave velocity (PWV), effects of topical capsaicin on carotid-radial artery, measurements in healthy subjects, MP2
R
RBC transfusions, guidelines for, in Intensive care setting, MP5
Readmission rate, after an index HF admission, risk factors associated in patients with both normal and reduced EF, 1
Red blood cell (RBC), lead testing of, for pediatric use, P23
Refractory delirium, basics of, P15
Renal disease, artificial neural networks model of cardiovascular risk in, 13
Reversible lower airway obstruction, in patients with cystic fibrosis, MP11
Rheumatoid arthritis (RA)
atherogenic properties of, effect on cholesterol efflux genes, MP12
PCI for AMI in patients with, 5
S
Secretome, directional, of in vitro normal primary HBE cells, 6
SOUND, implementation of structured handoff tool, in a pediatric emergency department, P19
ST-elevation myocardial infarction (STEMI), PCI and outcomes among elder patients with, 17
Stroke
factors affecting outcome and hospital resource utilization among elderly patients, P8
opthalmologic findings associated with recurrent, P13
plasma protein changes after tPA treatment in acute ischemic stroke patients, P17
proteomic profiles in long term follow-up of PFO in patients with, 29
Sumatriptan, treatment for migraine headaches in pediatric emergency department, MP8
T
TGF?-1, impact on fibronectin mRNA and protein expression in asthmatic epithelium, 12
Third molars, associated with an increased risk of mandibular fracture, MP3
Thrombotic thrombocytopenic purpura (TTP), in-hospital mortality in hospitalized patients with, 11
Tissue oxygen saturation (StO2), determinants of post-ischemic reactive hyperemia, 3
Tissue plasminogen activator (tPA), plasma protein changes after treatment in acute ischemic stroke patients, P17
Troponin, comparison based on patient demographic characteristics, 16
U
United States, trends in alcoholic hepatitis related hospitalizations cost and mortality in, P6
Urinary biomarkers, association between AKI and mortality, 20